Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Nuvectis Pharma, Inc. (NVCT) had Weighted-Average Shares Outstanding (Diluted) of 23.41M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-6.05M |
|
-- |
|
-- |
|
$6.26M |
|
$-6.26M |
|
$0.21M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
$-6.05M |
|
$-6.26M |
|
$-6.26M |
|
23.41M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
23.41M |
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$25.40M |
|
-- |
|
-- |
|
$25.40M |
|
$11.18M |
|
-- |
|
-- |
|
$11.18M |
|
$14.22M |
|
$14.22M |
|
$14.22M |
|
26.52M |
|
| Cash Flow Statement Financials | |
$-6.51M |
|
-- |
|
$0.01M |
|
$31.63M |
|
$25.13M |
|
$-6.50M |
|
$1.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.55% |
|
-42.55% |
|
-23.82% |
|
-42.55% |
|
$0.54 |
|
$-0.28 |
|
$-0.28 |
|